Exaggerated neurological side-effects of oral and intravesical oxybutynin in a patient with multiple sclerosis

Spinal Cord. 1997 Mar;35(3):190-1. doi: 10.1038/sj.sc.3100316.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Cholinergic Antagonists / administration & dosage
  • Cholinergic Antagonists / adverse effects*
  • Female
  • Humans
  • Mandelic Acids / administration & dosage
  • Mandelic Acids / adverse effects*
  • Multiple Sclerosis / complications*
  • Solutions

Substances

  • Cholinergic Antagonists
  • Mandelic Acids
  • Solutions
  • oxybutynin